Ortivus AB (publ) (ORTI-A.ST)
SEK 3.16
(0.0%)
SEK 3.16
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 55.4 Million SEK | 2.0% |
| 2022 | 54.31 Million SEK | 26.27% |
| 2021 | 43.01 Million SEK | -8.23% |
| 2020 | 46.87 Million SEK | 79.0% |
| 2019 | 26.18 Million SEK | 2.63% |
| 2018 | 25.51 Million SEK | 34.4% |
| 2017 | 18.98 Million SEK | -54.82% |
| 2016 | 42.02 Million SEK | -21.72% |
| 2015 | 53.68 Million SEK | -15.4% |
| 2014 | 63.45 Million SEK | 224.27% |
| 2013 | 19.56 Million SEK | -11.07% |
| 2012 | 22 Million SEK | 0.01% |
| 2011 | 22 Million SEK | 32.86% |
| 2010 | 16.56 Million SEK | -79.17% |
| 2009 | 79.5 Million SEK | 6.34% |
| 2008 | 74.76 Million SEK | -17.32% |
| 2007 | 90.42 Million SEK | -16.17% |
| 2006 | 107.86 Million SEK | -14.76% |
| 2005 | 126.54 Million SEK | 267.92% |
| 2004 | 34.39 Million SEK | -7.77% |
| 2003 | 37.29 Million SEK | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 51.3 Million SEK | -7.4% |
| 2024 Q2 | 56.84 Million SEK | 10.8% |
| 2023 FY | 55.4 Million SEK | 2.0% |
| 2023 Q1 | 53.24 Million SEK | -1.96% |
| 2023 Q2 | 43.93 Million SEK | -17.5% |
| 2023 Q3 | 51.45 Million SEK | 17.12% |
| 2023 Q4 | 55.4 Million SEK | 7.67% |
| 2022 Q4 | 54.31 Million SEK | 76.24% |
| 2022 FY | 54.31 Million SEK | 26.27% |
| 2022 Q3 | 30.81 Million SEK | -31.67% |
| 2022 Q1 | 41.48 Million SEK | -3.57% |
| 2022 Q2 | 45.1 Million SEK | 8.73% |
| 2021 FY | 43.01 Million SEK | -8.23% |
| 2021 Q3 | 45.81 Million SEK | 4.61% |
| 2021 Q1 | 55.77 Million SEK | 19.0% |
| 2021 Q2 | 43.79 Million SEK | -21.49% |
| 2021 Q4 | 43.01 Million SEK | -6.11% |
| 2020 Q3 | 44.44 Million SEK | -19.72% |
| 2020 Q1 | 40.62 Million SEK | 55.13% |
| 2020 Q2 | 55.35 Million SEK | 36.27% |
| 2020 FY | 46.87 Million SEK | 79.0% |
| 2020 Q4 | 46.87 Million SEK | 5.47% |
| 2019 Q1 | 28.29 Million SEK | 10.87% |
| 2019 FY | 26.18 Million SEK | 2.63% |
| 2019 Q2 | 22.63 Million SEK | -20.0% |
| 2019 Q3 | 19.33 Million SEK | -14.58% |
| 2019 Q4 | 26.18 Million SEK | 35.45% |
| 2018 Q1 | 22.13 Million SEK | 16.57% |
| 2018 Q4 | 25.51 Million SEK | 4.86% |
| 2018 FY | 25.51 Million SEK | 34.4% |
| 2018 Q3 | 24.33 Million SEK | 0.99% |
| 2018 Q2 | 24.09 Million SEK | 8.87% |
| 2017 Q1 | 40.05 Million SEK | -4.69% |
| 2017 Q2 | 24.83 Million SEK | -38.01% |
| 2017 Q4 | 18.98 Million SEK | -5.5% |
| 2017 FY | 18.98 Million SEK | -54.82% |
| 2017 Q3 | 20.08 Million SEK | -19.09% |
| 2016 Q2 | 55.53 Million SEK | -4.8% |
| 2016 FY | 42.02 Million SEK | -21.72% |
| 2016 Q1 | 58.32 Million SEK | 8.65% |
| 2016 Q4 | 42.02 Million SEK | -26.1% |
| 2016 Q3 | 56.86 Million SEK | 2.41% |
| 2015 Q2 | 71.59 Million SEK | 9.44% |
| 2015 Q4 | 53.68 Million SEK | -10.97% |
| 2015 Q1 | 65.42 Million SEK | 3.1% |
| 2015 FY | 53.68 Million SEK | -15.4% |
| 2015 Q3 | 60.3 Million SEK | -15.78% |
| 2014 Q4 | 63.45 Million SEK | 19.39% |
| 2014 FY | 63.45 Million SEK | 224.27% |
| 2014 Q3 | 53.14 Million SEK | 46.77% |
| 2014 Q2 | 36.21 Million SEK | 73.55% |
| 2014 Q1 | 20.86 Million SEK | 6.63% |
| 2013 Q3 | 12.08 Million SEK | -8.26% |
| 2013 Q1 | 17.17 Million SEK | -21.97% |
| 2013 Q4 | 19.56 Million SEK | 61.91% |
| 2013 FY | 19.56 Million SEK | -11.07% |
| 2013 Q2 | 13.17 Million SEK | -23.28% |
| 2012 Q1 | 37.84 Million SEK | 72.01% |
| 2012 Q2 | 19.15 Million SEK | -49.4% |
| 2012 Q3 | 13.4 Million SEK | -30.02% |
| 2012 FY | 22 Million SEK | 0.01% |
| 2012 Q4 | 22 Million SEK | 64.19% |
| 2011 Q4 | 22 Million SEK | 28.7% |
| 2011 FY | 22 Million SEK | 32.86% |
| 2011 Q1 | 13.45 Million SEK | -18.77% |
| 2011 Q2 | 17.28 Million SEK | 28.47% |
| 2011 Q3 | 17.09 Million SEK | -1.06% |
| 2010 FY | 16.56 Million SEK | -79.17% |
| 2010 Q4 | 16.56 Million SEK | 0.0% |
| 2009 FY | 79.5 Million SEK | 6.34% |
| 2008 FY | 74.76 Million SEK | -17.32% |
| 2007 FY | 90.42 Million SEK | -16.17% |
| 2006 FY | 107.86 Million SEK | -14.76% |
| 2005 FY | 126.54 Million SEK | 267.92% |
| 2004 FY | 34.39 Million SEK | -7.77% |
| 2003 FY | 37.29 Million SEK | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AddLife AB (publ) | 7.78 Billion SEK | 99.288% |
| Biotage AB (publ) | 1.27 Billion SEK | 95.651% |
| Bonesupport Holding AB (publ) | 143.63 Million SEK | 61.43% |
| Doxa AB (publ) | 280.8 Million SEK | 80.27% |
| Elekta AB (publ) | 21.61 Billion SEK | 99.744% |
| iZafe Group AB (publ) | 9.26 Million SEK | -498.218% |
| Ortivus AB (publ) | 55.4 Million SEK | 0.0% |
| Q-linea AB (publ) | 42.34 Million SEK | -30.848% |
| S2Medical AB (publ) | 19.74 Million SEK | -180.519% |
| Synsam AB (publ) | 5.52 Billion SEK | 98.997% |